A Novel Prognostic Signature Associated With the Tumor Microenvironment in Kidney Renal Clear Cell Carcinoma

Abstract

BackgroundThe tumor microenvironment (TME) is a complex and evolving environment, and the tumor immune microenvironment in kidney renal clear cell carcinoma (KIRC) has a strong suppressive profile. This study investigates the potential prognostic role and value of genes of the tumor microenvironment in KIRC.MethodsThe transcriptome sequencing data of 530 cases and 39 cases of KIRC and the corresponding clinical prognosis information were downloaded from TCGA data and GEO data, respectively, and TME-related gene expression profiles were extracted. A prognostic signature was constructed and evaluated using univariate Cox regression analysis and LASSO regression analysis. Gene set enrichment analysis (GSEA) was used to obtain the biological process of gene enrichment in patients with high and low-risk groups.ResultsA prognostic signature consisting of eight TME-related genes (LRFN1, CSF1, UCN, TUBB2B, SERPINF1, ADAM8, ABCB4, CCL22) was constructed. Kaplan-Meier survival analysis yielded significantly lower survival times for patients in the high-risk group than in the low-risk group, and the AUC values for the ROC curves of this prognostic signature were essentially greater than 0.7, and univariate and multifactorial Cox regression analyses indicated that the risk score was independent risk factors for KIRC prognosis. GSEA analysis showed that immune-related biological processes were enriched in the high-risk group and that risk values were strongly associated with multiple immune cell scores and immune checkpoint-related genes (PDCD1, CTLA4).ConclusionsThe prognostic signature can accurately predict the prognosis of KIRC patients, which may provide new ideas for future precision immunotherapy of KIRC.

Prognostic analysis of anoikis-related genes in bladder cancer: An observational study

“…Based on these genes, we constructed a risk model that effectively predicted the prognosis of BLCA patients. [21]…”

“…Based on these genes, we constructed a risk model that effectively predicted the prognosis of BLCA patients. [21] CALR, situated within the Endoplasmic Reticulum (ER), is involved in various cellular processes. CALR surface expression on BLCA cells facilitates the recognition and clearance by phagocytes, thereby initiating an immune response against cancer.…”

Comprehensive bioinformatics analysis unveils THEMIS2 as a carcinogenic indicator related to immune infiltration and prognosis of thyroid cancer

“…Least absolute shrinkage and selection operator (LASSO) regression analysis was performed to identify hub genes correlated with the development of THCA. The risk score was calculated using the following formula: risk score = 12 , with Coef j referring to the coefficient calculated using the LASSO method and Xj representing gene expression. We investigated the potential diagnostic value of the hub genes for distinguishing thyroid cancer from normal samples using receiver operating characteristic (ROC) curve analysis using the pROC function in R. This allowed us to calculate the area under the curve (AUC) when screening signature genes and estimating their corresponding diagnostic value.…”

N6-methyladenosine (m6A) reader IGF2BP1 facilitates clear-cell renal cell carcinoma aerobic glycolysis

“…Renal cell carcinoma (RCC) acts as the second leading cause of urological malignant neoplasm-related death and tens of thousands of newly diagnosed cases are reported by global statistics ( Cao et al, 2022 ; Kench et al, 2022 ). More precisely, clear cell renal cell carcinoma (ccRCC) is a higher invasive subtype of RCC, comprising 80–90% of RCC patients ( Liu et al, 2022b ; Pei et al, 2022 ). Unfortunately, the chemotherapy or radiotherapy is largely ineffective for all renal cancer subtypes ( Vassiliou et al, 2022 ; Yin & Zheng, 2022 ).…”